Gonçalves Isabel, Edsfeldt Andreas, Colhoun Helen M, Shore Angela C, Palombo Carlo, Natali Andrea, Fredrikson Gunilla Nordin, Björkbacka Harry, Wigren Maria, Bengtsson Eva, Östling Gerd, Aizawa Kunihiko, Casanova Francesco, Persson Margaretha, Gooding Kim, Gates Phil, Khan Faisel, Looker Helen C, Adams Fiona, Belch Jill, Pinnola Silvia, Venturi Elena, Kozakova Michaela, Gan Li-Ming, Schnecke Volker, Nilsson Jan
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Medical Research Institute, University of Dundee, Dundee, UK.
BMC Cardiovasc Disord. 2016 Sep 5;16(1):171. doi: 10.1186/s12872-016-0346-8.
Activation of the renin-angiotensin-aldosterone-system (RAAS) has been proposed to contribute to development of vascular complications in type 2 diabetes (T2D). The aim of the present study was to determine if plasma renin levels are associated with the severity of vascular changes in subjects with and without T2D.
Renin was analyzed by the Proximity Extension Assay in subjects with (n = 985) and without (n = 515) T2D participating in the SUMMIT (SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools) study and in 205 carotid endarterectomy patients. Vascular changes were assessed by determining ankle-brachial pressure index (ABPI), carotid intima-media thickness (IMT), carotid plaque area, pulse wave velocity (PWV) and the reactivity hyperemia index (RHI).
Plasma renin was elevated in subjects with T2D and demonstrated risk factor-independent association with prevalent cardiovascular disease both in subjects with and without T2D. Renin levels increased with age, body mass index, HbA1c and correlated inversely with HDL. Subjects with T2D had more severe carotid disease, increased arterial stiffness, and impaired endothelial function. Risk factor-independent associations between renin and APBI, bulb IMT, carotid plaque area were observed in both T2D and non-T2D subjects. These associations were independent of treatment with RAAS inhibitors. Only weak associations existed between plasma renin and the expression of pro-inflammatory and fibrous components in plaques from 205 endarterectomy patients.
Our findings provide clinical evidence for associations between systemic RAAS activation and atherosclerotic burden and suggest that this association is of particular importance in T2D.
肾素-血管紧张素-醛固酮系统(RAAS)的激活被认为与2型糖尿病(T2D)血管并发症的发生有关。本研究的目的是确定血浆肾素水平是否与有或无T2D的受试者血管变化的严重程度相关。
在参与SUMMIT(创新糖尿病工具的微血管和大血管硬终点替代标志物)研究的有T2D(n = 985)和无T2D(n = 515)的受试者以及205例颈动脉内膜切除术患者中,通过邻位延伸分析测定肾素。通过测定踝臂压力指数(ABPI)、颈动脉内膜中层厚度(IMT)、颈动脉斑块面积、脉搏波速度(PWV)和反应性充血指数(RHI)评估血管变化。
T2D患者的血浆肾素升高,并且在有和无T2D的受试者中均显示出与心血管疾病患病率的危险因素无关的关联。肾素水平随年龄、体重指数、糖化血红蛋白升高而升高,与高密度脂蛋白呈负相关。T2D患者有更严重的颈动脉疾病、动脉僵硬度增加和内皮功能受损。在T2D和非T2D受试者中均观察到肾素与ABPI、球部IMT、颈动脉斑块面积之间存在危险因素无关的关联。这些关联独立于RAAS抑制剂治疗。在205例内膜切除术患者的斑块中,血浆肾素与促炎和纤维成分的表达之间仅存在微弱关联。
我们的研究结果为全身性RAAS激活与动脉粥样硬化负担之间的关联提供了临床证据,并表明这种关联在T2D中尤为重要。